The current price of ZLAB is $22.60 — it has decreased by 0.88% since the previous close. Data as of Nov 5, 2026.
ZLAB is up 1.35% over the past week, down 11.65% over the past month and down 2.38% over the past year. The price is above its 200-day moving average of $21.03.
Analysts' average 12-month price target for ZLAB is $53.75, which implies 137.83% upside from the current price. Individual estimates range from $35.00 to $75.00.
Zai Lab Limited has a market capitalization of $2.55B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Zai Lab Limited posted a loss of $0.41 per share against an estimate of -$0.5918, beating expectations by 30.72%. Upcoming reports are listed in the earnings calendar.
Zai Lab Limited reported revenue of $108.21M in its most recent quarter, which has decreased by 6.79% compared with the same quarter a year earlier. Analysts had expected $107.9M.
Zai Lab Limited has not paid any dividends over the past year.
In the latest trading session ZLAB moved between $22.04 and $23.04, a range of 4.40% of its current price.
Over the past 52 weeks ZLAB has traded between $15.96 and $27.50. The current price is 17.82% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.